| Net Cash Provided by (Used in) Operating Activities |
$532,000,000 |
USD |
460% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$221,000,000 |
USD |
-51% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$90,000,000 |
USD |
-32% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
1,250,000,000 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$221,000,000 |
USD |
|
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$1,114,000,000 |
USD |
-10% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$423,000,000 |
USD |
-1.6% |
Q2 2025 |
FY 2027 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.17 |
pure |
0% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Gross |
$1,540,000,000 |
USD |
1.1% |
Q2 2025 |
FY 2027 |
| Operating Lease, Liability |
$378,000,000 |
USD |
-5.3% |
Q2 2025 |
FY 2027 |
| Payments to Acquire Property, Plant, and Equipment |
$105,000,000 |
USD |
54% |
Q3 2025 |
Q1 2026 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$1,707,000,000 |
USD |
104% |
Q3 2025 |
Q1 2026 |
| Lessee, Operating Lease, Liability, to be Paid |
$516,000,000 |
USD |
-8.5% |
Q2 2025 |
FY 2027 |
| Property, Plant and Equipment, Gross |
$10,364,000,000 |
USD |
0.82% |
Q3 2025 |
Q1 2026 |
| Operating Lease, Liability, Current |
$61,000,000 |
USD |
0% |
Q2 2025 |
FY 2027 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$64,000,000 |
USD |
1.6% |
Q2 2025 |
FY 2027 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.09 |
pure |
0% |
Q2 2025 |
FY 2027 |
| Deferred Income Tax Expense (Benefit) |
$25,000,000 |
USD |
-733% |
Q3 2025 |
Q1 2026 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$138,000,000 |
USD |
-16% |
Q2 2025 |
FY 2027 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Unrecognized Tax Benefits |
$107,000,000 |
USD |
-5.3% |
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q1 2026 |
| Depreciation, Depletion and Amortization |
$72,000,000 |
USD |
12% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$1,117,000,000 |
USD |
2.2% |
Q2 2025 |
FY 2027 |
| Interest Expense |
$333,000,000 |
USD |
0% |
Q4 2024 |
Q2 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |